Shares in homegrown pharmaceuticals firm Ranbaxy Labs rose 1.8 percent in early Mumbai trading after a US federal court ruled in its favour in a landmark “pay-to-delay†case.
first published: Dec 8, 2014 11:30 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

